Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2012
03/15/2012US20120065271 Method of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
03/15/2012US20120065263 Retrovirus-infection inhibitor
03/15/2012US20120065247 Modulating ires-mediated translation
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065188 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/15/2012US20120065186 Antimicrobial compositions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065182 Stabilizing compositions for antibiotics and methods of use
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065170 Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
03/15/2012US20120065169 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
03/15/2012US20120065167 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
03/15/2012US20120065157 Particulate-soluble glucan preparation
03/15/2012US20120065156 Uracyl Spirooxetane Nucleosides
03/15/2012US20120065134 Cd40-l inhibitory phylomer peptides
03/15/2012US20120065126 Pharmaceutical Compositions Containing Antifungal Peptides
03/15/2012US20120065125 Methods and compositions for the treatment of cancer or other diseases
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064600 Anti-5t4 antibodies and uses thereof
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064179 Bicarbonate solution for bioavailable magnesium and uses thereof
03/15/2012US20120064151 Enhanced immune response in avian species
03/15/2012US20120064149 High-clarity aqueous concentrates of 4-hexylresorcinol
03/15/2012US20120064139 Antimicrobial sucralfate paste methods and compositions
03/15/2012US20120064136 Anti-aging and wrinkle treatment methods using nanoemulsion compositions
03/15/2012US20120064135 Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
03/15/2012US20120064132 Antibacterial medical equipment and method for producing the same
03/15/2012US20120064128 Nano-metallic alloy delivery system for treatment of infected cells and legions
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
03/15/2012US20120064126 Dry powder formulations and methods for treating pulmonary diseases
03/15/2012US20120064125 Agr-mediated inhibition of methicillin resistant staphylococcus aureus
03/15/2012US20120064124 Macrolide dosage forms
03/15/2012US20120064122 Treatment of autoimmune inflammation using mir-155
03/15/2012US20120064117 Tetravalent influenza vaccine and use thereof
03/15/2012US20120064115 Recombinant virus-like particles encoded by multi-gene vector
03/15/2012US20120064114 Use of e. coli surface antigen 3 sequences for the export of heterologous antigens
03/15/2012US20120064112 Recombinant newcastle disease viruses useful as vaccines or vaccine vectors
03/15/2012US20120064110 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
03/15/2012US20120064108 Glycoconjugate vaccines
03/15/2012US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa
03/15/2012US20120064105 Engineered Type IV Pilin of Clostridium difficile
03/15/2012US20120064096 BTLA Antibodies and Uses Thereof
03/15/2012US20120064094 Serotonin 5-HT3 Receptor Antagonists for Use in the Treatment of Lesional Vestibular Disorders
03/15/2012US20120064093 Antibody
03/15/2012US20120064085 ANTI-INFLUENZA M2e ANTIBODY
03/15/2012US20120064081 Anti-kir3d antibodies
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064048 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/15/2012US20120064037 Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/15/2012US20120064033 Modulation of regulatory t cells by human il-18
03/15/2012US20120064027 Absorbable adhesive paste
03/15/2012US20120064015 Food Additive Composition as an Agent for Reducing the Adhesion of Dental Biofilms in Sweetened Products
03/15/2012US20120064013 Foamable topical composition
03/15/2012US20120064000 Human Monoclonal Antibodies Against Hendra And Nipah Viruses
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012US20120061267 MediTowel Anti-Fungal Wipe
03/15/2012US20120060834 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
03/15/2012US20120060258 Composition for use in decreasing the transmission of human pathogens
03/15/2012DE102010040705A1 Blütenextrakt von Primula flos zur Behandlung und Prophylaxe von Entzündungen oder viralen Infektionen Primula flower extract of flos for the treatment and prophylaxis of infections or viral infections
03/15/2012CA2810851A1 Compositions and methods for the removal of biofilms
03/15/2012CA2810603A1 Immunogenic composition comprising neisseria menigitidis macrophage infectivity potentiator protein
03/15/2012CA2810021A1 Boron-containing small molecules
03/15/2012CA2809624A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012CA2809203A1 Novel use
03/14/2012EP2428226A1 Antibody targeting compounds
03/14/2012EP2428221A1 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide molecule and antibody composition
03/14/2012EP2428220A1 Dengue vaccine, pharmaceutical composition comprising the same, and nucleotide molecule
03/14/2012EP2428214A1 Compositions for the vaginal and oral administration of lactobacillus and uses thereof
03/14/2012EP2427476A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
03/14/2012EP2427446A1 Inhibitors of sialidase or sialidase-like enzymes
03/14/2012EP2427442A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
03/14/2012EP2427213A2 Alpha thymosin peptides as vaccine enhancers
03/14/2012EP2427210A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
03/14/2012EP2427206A1 Novel compositions for treating pseudomonas infection
03/14/2012EP2427190A1 8-aza tetracycline compounds
03/14/2012EP2427186A2 Dihydroorotate-dehydrogenasee inhibitors as virostatic compounds
03/14/2012EP2427183A2 Therapeutic compounds
03/14/2012EP2427061A2 Gallium formulation for the treatment and prevention of infectious diseases
03/14/2012EP2427057A1 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/14/2012EP2321319B1 Antiviral compounds
03/14/2012EP2049112B1 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
03/14/2012EP1971608B1 Spiroketals
03/14/2012EP1910837B1 Methods and compositions for diagnosis and treatment of influenza
03/14/2012EP1868581B1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
03/14/2012EP1636171B1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulators
03/14/2012EP1629009B1 Compositions comprising large and small binding fragments of antibodies against the same toxin
03/14/2012EP1546194B1 Therapeutic uspa1-derived peptides
03/14/2012EP1455766B1 Thymosin alpha 1 peptide/polymer conjugates
03/14/2012EP1448984B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
03/14/2012EP1416958B2 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
03/14/2012CN202161075U 一种颈椎保健枕 One kind Cervical Pillow
03/14/2012CN1939445B Preparation and use for loquat-leaf extract
03/14/2012CN1939444B Preparation and use for loquat-shell aqueous extract
03/14/2012CN1903870B Single chain DNA having therapeutic action against virus infection disease
03/14/2012CN1785993B Preparation method of non natural isocoumarin and its 3,4-dihydro derivative and use thereof
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 1798